ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into HROWL's underlying financial health and market activity.
Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) technical indicators as of August 11, 2025: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess HROWL's price trends and potential future movements.
Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) stock performance overview as of August 11, 2025: The 52-week high is $25.73 (currently N/A below), and the 52-week low is $25 (currently N/A above). Over the past year, HROWL's performance is -0.95%, compared to the S&P 500's 20.13% change.
According to market data, Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) stock's recent performance metrics show that over the last month, HROWL is -1.65%, with a Year-to-Date (YTD) performance of -0.95%. Over the past year, the stock has seen a -0.95% change. These figures summarize HROWL's price movements across various periods, reflecting its historical returns.
According to current financial data, HROWL stock's P/E (TTM) ratio is -56.85, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for HROWL, including P/S (5.94), P/B (21.85), and P/FCF (-34.52), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.